{"id":35550,"date":"2025-07-14T13:12:15","date_gmt":"2025-07-14T07:42:15","guid":{"rendered":"https:\/\/edunovations.com\/currentaffairs\/?p=35550"},"modified":"2025-07-14T13:12:18","modified_gmt":"2025-07-14T07:42:18","slug":"malaria-medicine-for-infants","status":"publish","type":"post","link":"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/","title":{"rendered":"Malaria Medicine for Infants Approved: Coartem Baby Gets Swissmedic Nod for Newborn Treatment"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_84 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Malaria_medicine_for_infants_approved_by_Swissmedic_Coartem_Baby_becomes_the_first_antimalarial_drug_for_newborns_targeting_babies_weighing_2%E2%80%935_kg_Essential_update_for_government_exam_aspirants\" >Malaria medicine for infants approved by Swissmedic! Coartem Baby becomes the first antimalarial drug for newborns, targeting babies weighing 2\u20135 kg. Essential update for government exam aspirants.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#%F0%9F%8C%8D_Switzerland_Clears_First_Malaria_Medicine_for_Small_Babies\" >\ud83c\udf0d Switzerland Clears First Malaria Medicine for Small Babies<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Overview_of_the_Breakthrough\" >Overview of the Breakthrough<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Designed_for_Tiny_Lives\" >Designed for Tiny Lives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Clinical_Importance_Roll%E2%80%91out\" >Clinical Importance &amp; Roll\u2011out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Addressing_Child_Mortality\" >Addressing Child Mortality<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Support_Beyond_Drugs\" >Support Beyond Drugs<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#%F0%9F%93%8C_Why_This_News_Matters\" >\ud83d\udccc Why This News Matters<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Protection_for_the_Most_Vulnerable\" >Protection for the Most Vulnerable<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Closing_a_Vital_Treatment_Gap\" >Closing a Vital Treatment Gap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Aligns_with_Global_Health_Goals\" >Aligns with Global Health Goals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Boosts_Confidence_in_Pediatric_Medicine\" >Boosts Confidence in Pediatric Medicine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Valuable_for_Exam_Preparation\" >Valuable for Exam Preparation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#%F0%9F%95%B0_Historical_Context\" >\ud83d\udd70 Historical Context<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Past_Treatment_Landscape\" >Past Treatment Landscape<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Neglect_of_Neonatal_Malaria\" >Neglect of Neonatal Malaria<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Rising_Challenges\" >Rising Challenges<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Aiding_Global_Roll%E2%80%91out\" >Aiding Global Roll\u2011out<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Key_Takeaways_from_Coartem_Baby_Approval\" >Key Takeaways from Coartem Baby Approval<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#FAQs_Frequently_Asked_Questions\" >FAQs: Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#1_What_is_Coartem_Baby\" >1. What is Coartem Baby?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#2_Why_was_Coartem_Baby_developed\" >2. Why was Coartem Baby developed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#3_Who_approved_Coartem_Baby_for_use\" >3. Who approved Coartem Baby for use?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#4_Which_pharmaceutical_company_developed_Coartem_Baby\" >4. Which pharmaceutical company developed Coartem Baby?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#5_Which_countries_will_adopt_Coartem_Baby_next\" >5. Which countries will adopt Coartem Baby next?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#6_What_is_the_formulation_of_Coartem_Baby_like\" >6. What is the formulation of Coartem Baby like?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#7_What_is_the_significance_of_MAGHP_in_this_approval\" >7. What is the significance of MAGHP in this approval?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#8_Why_is_malaria_particularly_dangerous_for_babies\" >8. Why is malaria particularly dangerous for babies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#9_How_many_children_died_due_to_malaria_in_2023\" >9. How many children died due to malaria in 2023?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#10_Will_the_drug_be_affordable\" >10. Will the drug be affordable?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/edunovations.com\/currentaffairs\/national\/malaria-medicine-for-infants\/#Some_Important_Current_Affairs_Links\" >Some Important Current Affairs Links<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Malaria_medicine_for_infants_approved_by_Swissmedic_Coartem_Baby_becomes_the_first_antimalarial_drug_for_newborns_targeting_babies_weighing_2%E2%80%935_kg_Essential_update_for_government_exam_aspirants\"><\/span><strong>Malaria medicine for infants<\/strong> approved by Swissmedic! Coartem Baby becomes the first antimalarial drug for newborns, targeting babies weighing 2\u20135 kg. Essential update for government exam aspirants.<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%F0%9F%8C%8D_Switzerland_Clears_First_Malaria_Medicine_for_Small_Babies\"><\/span>\ud83c\udf0d Switzerland Clears First Malaria Medicine for Small Babies<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Overview_of_the_Breakthrough\"><\/span>Overview of the Breakthrough<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">On <strong>July 9, 2025<\/strong>, Swissmedic, Switzerland\u2019s medical regulatory authority, granted approval for <strong>Coartem Baby<\/strong> (also known as Riamet Baby), designed specifically for infants weighing between <strong>2\u202fkg and 5\u202fkg<\/strong>  Developed through a collaboration between <strong>Novartis<\/strong> and the <strong>Medicines for Malaria Venture (MMV)<\/strong>, this sweet-cherry flavored, dissolvable formulation of artemether-lumefantrine fills a critical treatment gap for newborns and very young infants, who were previously excluded from licensed malaria therapies <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Designed_for_Tiny_Lives\"><\/span>Designed for Tiny Lives<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Prior to this approval, infants weighing under ~4.5\u202fkg had no dedicated antimalarial treatment. Caregivers were forced to adapt higher-dose tablets for older children\u2014risking <strong>overdose<\/strong> and <strong>ineffective dosing<\/strong>  Coartem Baby is specially calibrated for neonates, with a formulation that dissolves in <strong>breast milk or water<\/strong>, ensuring <strong>accurate dosing<\/strong> and <strong>easy administration<\/strong> <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Clinical_Importance_Roll%E2%80%91out\"><\/span>Clinical Importance &amp; Roll\u2011out<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">This approval comes under Swissmedic\u2019s <strong>fast\u2011track Global Health Products (MAGHP)<\/strong> program, endorsed by the <strong>World Health Organization<\/strong> Eight malaria\u2011endemic African nations\u2014<strong>Burkina Faso, C\u00f4te d\u2019Ivoire, Kenya, Malawi, Mozambique, Nigeria, Tanzania<\/strong>, and <strong>Uganda<\/strong>\u2014have already agreed to accelerated approval within 90 days, paving the way for prompt deployment <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Addressing_Child_Mortality\"><\/span>Addressing Child Mortality<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Malaria remains one of the top killer diseases among children, with nearly <strong>600,000 deaths<\/strong> in 2023, <strong>76% of which occurred in children under five<\/strong>, especially in AfricaThis new pediatric formulation significantly enhances treatment equity and promises to <em>reduce mortality in the most vulnerable age group<\/em> <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Support_Beyond_Drugs\"><\/span>Support Beyond Drugs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Novartis commits to distributing Coartem Baby on a <strong>largely not-for-profit basis<\/strong> in afflicted regions However, experts emphasize that sustainable access will also depend on <strong>transparent pricing, adequate funding<\/strong>, and integration into <strong>national malaria control programs<\/strong>, particularly as global aid fluctuates .<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\" id=\"malaria-medicine-for-infants\"><img decoding=\"async\" src=\"https:\/\/static.toiimg.com\/thumb\/width-400,resizemode-4,msid-122332629\/Baby%20malaria%20(2).jpg\" alt=\"malaria medicine for infants\" title=\"malaria medicine for infants\"\/><figcaption class=\"wp-element-caption\">malaria medicine for infants<\/figcaption><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%F0%9F%93%8C_Why_This_News_Matters\"><\/span>\ud83d\udccc Why This News Matters<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Protection_for_the_Most_Vulnerable\"><\/span>Protection for the Most Vulnerable<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Neonates and low-weight infants are especially prone to <strong>severe malaria and mortality<\/strong>, yet lacked <strong>dosage-appropriate medication<\/strong>. Now, they have a <em>formulated, clinically tested<\/em>* treatment designed just for them .<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Closing_a_Vital_Treatment_Gap\"><\/span>Closing a Vital Treatment Gap<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Until now, clinicians relied on \u201cdiluted\u201d or improvised dosing of older-child tablets\u2014an <strong>unsafe and suboptimal method<\/strong>. Coartem Baby solves this long-standing public health challenge <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aligns_with_Global_Health_Goals\"><\/span>Aligns with Global Health Goals<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">This milestone supports WHO\u2019s objectives to <em>reduce malaria-related deaths<\/em> and amplify access to <em>lifesaving treatments for all age groups<\/em>, reinforcing commitments toward <strong>SDG 3: Good Health and Well\u2011being<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Boosts_Confidence_in_Pediatric_Medicine\"><\/span>Boosts Confidence in Pediatric Medicine<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The news highlights successful <strong>drug formulation for babies<\/strong>, encouraging innovation in pediatric pharmacology and potentially inspiring similar solutions for other infant diseases.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Valuable_for_Exam_Preparation\"><\/span>Valuable for Exam Preparation<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">For competitive exams like <strong>PSC, Civil Services, Banking, Railways<\/strong>, this story is a prime example of current affairs aligned with <strong>Health &amp; International Relations syllabus<\/strong>\u2014it showcases global cooperation, SDG alignment, and pharmaceutical innovation.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%F0%9F%95%B0_Historical_Context\"><\/span>\ud83d\udd70 Historical Context<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Past_Treatment_Landscape\"><\/span>Past Treatment Landscape<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Since Coartem\u2019s debut in 1999, Novartis has provided <strong>over 1.1 billion antimalarial courses<\/strong>, primarily for children weighing above 5\u202fkg However, <strong>infants<\/strong> were excluded from early clinical trials due to <strong>immature metabolism and liver function<\/strong>, necessitating new dosage formulations <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neglect_of_Neonatal_Malaria\"><\/span>Neglect of Neonatal Malaria<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">There was a <strong>misconception<\/strong> that infants were less susceptible due to maternal immunity. However, rising evidence shows <strong>3\u201318% infection rates<\/strong> even in infants under six months, necessitating targeted drug development .<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Rising_Challenges\"><\/span>Rising Challenges<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Malaria control has faced setbacks due to <strong>global funding cuts<\/strong> and expanding transmission zones driven by <strong>climate change<\/strong>, challenging progress in malaria-endemic zonesApproval of Coartem Baby marks a <strong>new strategic play<\/strong> in overcoming such hurdles.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aiding_Global_Roll%E2%80%91out\"><\/span>Aiding Global Roll\u2011out<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Leveraging the MAGHP fast-track mechanism with WHO aligns with historical efforts to accelerate access to <strong>vital drugs in low-income countries<\/strong>, such as HIV\/AIDS and tuberculosis medications, demonstrating strengthened commitment.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Coartem_Baby_Approval\"><\/span>Key Takeaways from Coartem Baby Approval<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>S.No<\/th><th>Key Takeaway<\/th><\/tr><\/thead><tbody><tr><td>1<\/td><td><em>Coartem Baby<\/em> is the <strong>first antimalarial approved<\/strong> for infants weighing <strong>2\u20135\u202fkg<\/strong>.<\/td><\/tr><tr><td>2<\/td><td>It contains <strong>artemether-lumefantrine<\/strong>, adjusted dose with <strong>dissolvable, cherry-flavored<\/strong> form for easy administration.<\/td><\/tr><tr><td>3<\/td><td>Approved by <strong>Swissmedic<\/strong> under <strong>MAGHP fast-track<\/strong>, with support from <strong>WHO<\/strong>.<\/td><\/tr><tr><td>4<\/td><td>Eight African countries (e.g., Nigeria, Kenya) fast-tracked approval, streamlining rollout in malarial zones.<\/td><\/tr><tr><td>5<\/td><td>Novartis will distribute it mostly on a <strong>not-for-profit basis<\/strong>, boosting access amid global health funding uncertainties.<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">malaria medicine for infants<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_Frequently_Asked_Questions\"><\/span><strong>FAQs: Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_What_is_Coartem_Baby\"><\/span>1. What is Coartem Baby?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Coartem Baby is a pediatric formulation of the antimalarial drug artemether-lumefantrine, approved for treating malaria in newborns and infants weighing between 2\u20135 kg.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Why_was_Coartem_Baby_developed\"><\/span>2. Why was Coartem Baby developed?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">It was developed to close the treatment gap for neonates who previously had no approved and accurate dosage for malaria, which is often deadly in this age group.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_Who_approved_Coartem_Baby_for_use\"><\/span>3. Who approved Coartem Baby for use?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Swissmedic, Switzerland\u2019s national medical regulator, granted approval under the MAGHP (Medicines for Global Health Products) pathway in partnership with WHO.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_Which_pharmaceutical_company_developed_Coartem_Baby\"><\/span>4. Which pharmaceutical company developed Coartem Baby?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The drug was developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Which_countries_will_adopt_Coartem_Baby_next\"><\/span>5. Which countries will adopt Coartem Baby next?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Eight malaria-endemic African nations\u2014Burkina Faso, C\u00f4te d\u2019Ivoire, Kenya, Malawi, Mozambique, Nigeria, Tanzania, and Uganda\u2014have agreed to approve it within 90 days.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"6_What_is_the_formulation_of_Coartem_Baby_like\"><\/span>6. What is the formulation of Coartem Baby like?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">It is a sweet cherry\u2013flavored dispersible tablet that can dissolve in water or breast milk, making it easier for infants to ingest.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"7_What_is_the_significance_of_MAGHP_in_this_approval\"><\/span>7. What is the significance of MAGHP in this approval?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">MAGHP is a WHO-backed fast-track process for getting medicines approved for global health emergencies, especially for low-income countries.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"8_Why_is_malaria_particularly_dangerous_for_babies\"><\/span>8. Why is malaria particularly dangerous for babies?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Infants have underdeveloped immune systems and are highly vulnerable to severe complications and death due to malaria.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"9_How_many_children_died_due_to_malaria_in_2023\"><\/span>9. How many children died due to malaria in 2023?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">According to WHO data, around 600,000 people died due to malaria in 2023, with 76% of them being children under the age of five.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"10_Will_the_drug_be_affordable\"><\/span>10. Will the drug be affordable?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Yes, Novartis plans to distribute Coartem Baby on a largely not-for-profit basis in malaria-affected regions to improve accessibility.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Some_Important_Current_Affairs_Links\"><\/span>Some Important Current Affairs Links<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/national\/\" target=\"_blank\" rel=\"noreferrer noopener\">State Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--2\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/sports\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sports Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--3\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/international\/\" target=\"_blank\" rel=\"noreferrer noopener\">International Current Affairs<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/banking\/\" target=\"_blank\" rel=\"noreferrer noopener\">Banking Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/railway\/\" target=\"_blank\" rel=\"noreferrer noopener\">Railways Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/defence\/\" target=\"_blank\" rel=\"noreferrer noopener\">Defence Current Affairs<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--4\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs?newsmaticargs=custom&amp;posts=today\" target=\"_blank\" rel=\"noreferrer noopener\">Daily Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--5\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairsinhindi\/\" target=\"_blank\" rel=\"noreferrer noopener\">Current Affairs In Hindi<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--6\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/news-and-notifications\/\" target=\"_blank\" rel=\"noreferrer noopener\">News and Notifications<\/a><\/div>\n<\/div>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.edunovations.quiz\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"900\" height=\"150\" src=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1.jpg\" alt=\"Download this App for Daily Current Affairs MCQ&#039;s\" class=\"wp-image-247\" title=\"\" srcset=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1.jpg 900w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1-300x50.jpg 300w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1-768x128.jpg 768w\" sizes=\"(max-width: 900px) 100vw, 900px\" \/><\/a><figcaption class=\"wp-element-caption\">Download this App for Daily Current Affairs MCQ&#8217;s<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\" id=\"News-Website-Development-Company\"><a href=\"https:\/\/www.martindiainfotech.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"900\" height=\"150\" src=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner.png\" alt=\"News Website Development Company\" class=\"wp-image-438\" title=\"News Website Development Company\" srcset=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner.png 900w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner-300x50.png 300w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner-768x128.png 768w\" sizes=\"(max-width: 900px) 100vw, 900px\" \/><\/a><figcaption class=\"wp-element-caption\">News Website Development Company<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Malaria medicine for infants approved by Swissmedic! Coartem Baby becomes the first antimalarial drug for newborns, targeting babies weighing 2\u20135 kg. Essential update for government exam aspirants. \ud83c\udf0d Switzerland Clears First Malaria Medicine for Small Babies Overview of the Breakthrough On July 9, 2025, Swissmedic, Switzerland\u2019s medical regulatory authority, granted approval for Coartem Baby (also&#8230;<\/p>\n","protected":false},"author":6,"featured_media":35587,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,158],"tags":[24895,24897,23293,24896,4972,24892,24893,24898,24899,24894],"class_list":["post-35550","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national","category-research_invention_discovery","tag-african-health-policy","tag-coartem-baby","tag-competitive-exam-current-affairs","tag-global-health-news","tag-infant-health","tag-malaria-treatment","tag-novartis-mmv-partnership","tag-pediatric-malaria","tag-swissmedic-approval","tag-who-maghp"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts\/35550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/comments?post=35550"}],"version-history":[{"count":2,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts\/35550\/revisions"}],"predecessor-version":[{"id":35588,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts\/35550\/revisions\/35588"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/media\/35587"}],"wp:attachment":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/media?parent=35550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/categories?post=35550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/tags?post=35550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}